AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2023 Issue 4; New/Revised ICD-10-CM Codes

Myelin Oligodendrocyte Glycoprotein Antibody Disease

Code G37.8, Other specified demyelinating diseases of central nervous system, was expanded to create new codes to identify myelin oligodendrocyte glycoprotein antibody disease (G37.81), and other specified demyelinating diseases of central nervous system (G37.89).Myelin oligodendrocyte glycoprotein antibody disease (MOG-AD) is a rare, antibody-mediated inflammatory demyelinating condition of the central nervous system. MOG-AD is characterized by attacks of immune-mediated demyelination predominantly targeting the optic nerves, brain, and spinal cord. The condition does not meet the diagnostic criteria for multiple sclerosis or other known neuroinflammatory conditions.MOG-AD occurs slightly more in women. Although it may occur in...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.